by Jordana Choucair | Apr 14, 2022 | Life Sciences
Pfizer Inc/BioNTech SE said a booster dose of their COVID-19 vaccine strengthened the immune response against COVID-19 and the omicron variant among children ages 5 to 11 in a small trial. The biotech company said they will ask the Food and Drug Administration (FDA)...
by Jordana Choucair | Apr 13, 2022 | Life Sciences
A recent report from the American Society of Health-System Pharmacist found that drug spend in the U.S. increased 7.7 percent in 2021. The increase was driven by utilization (a 4.8 percent increase), price (a 1.9 percent increase), and new drugs (a 1.1 percent)....
by Jordana Choucair | Apr 12, 2022 | Life Sciences
The Food and Drug Administration (FDA) last week held discussions with five states about creating a way to import drugs from Canada. Importation could allow states to take advantage of lower drug prices abroad without the need for direct action to limit prices in the...
by Jordana Choucair | Apr 7, 2022 | Life Sciences
A new report from the American Society of Health-System Pharmacists found that drug spending in the U.S. hit $576.9 billion in 2021, a 7.7 percent increase over 2020. Hospitals accounted for $39.6 billion of that spending, with an 8.4 percent growth from 2020 to 2021....
by Jordana Choucair | Apr 6, 2022 | Life Sciences
Advisors to the Food and Drug Administration (FDA) will start to develop a long-term strategy for COVID-19 vaccinations. The discussion is expected to include the viability of an annual COVID-19 vaccine, which would require scientific models to predict how COVID-19...
by Jordana Choucair | Mar 30, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized a second COVID-19 booster shot for adults over the age of 50 as soon as four months after their initial booster dose. The Centers for Disease Control and Prevention (CDC) gave its permissive recommendation to the move,...
Recent Comments